Csl Share Price

Csl has delivered biotechnology excellence for over a century. Today, with the combined expertise of csl behring, csl plasma, csl seqirus and csl vifor, csl’s offerings are more diverse than ever. Our parent company, csl, headquartered in melbourne, australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

Csl is committed to protecting public health and improving and saving the lives of patients with rare and serious diseases through the development, manufacture and reliable supply of high-quality medicines. Today, csl – including our three businesses, csl behring, csl seqirus and csl vifor – provides. Csl consists of csl behring, csl seqirus and csl vifor.

Csl plasma operates one of the world’s largest and most sophisticated plasma collection networks, with nearly 330 plasma donation centers globally, including the u.s. Csl was established in australia in 1916. Over the ensuing years, csl provided australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against.

Derived from the expression 'securing health for all of us', csl seqirus is one of the world's largest influenza. Csl is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron.